Skip to content
10-Q

Quarterly Report

ANTIVIRAL TECHNOLOGIES, INC.

0001137050-12-000165

← back to feed
Filed
May 14, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2012 · Mar 31, 2012 150M sh
Operating Cash Flow Q1 2012 · Mar 31, 2012 −$1.11M
Operating Cash Flow Q1 2012 · Mar 31, 2011 −$34.28K
Stockholders Equity Q1 2012 · Mar 31, 2012 −$2.03M
Stockholders Equity Q1 2012 · Dec 31, 2011 −$1.93M
Total Liabilities Q1 2012 · Mar 31, 2012 $2.44M
Total Liabilities Q1 2012 · Dec 31, 2011 $2.34M
Current Assets Q1 2012 · Mar 31, 2012 $1.82K
Current Assets Q1 2012 · Dec 31, 2011 $4.88K
Total Assets Q1 2012 · Mar 31, 2012 $414.07K
Total Assets Q1 2012 · Dec 31, 2011 $405.56K
Sga Expense Q1 2012 · Mar 31, 2012 $1.86M
Sga Expense Q1 2012 · Mar 31, 2011 $94.11K
Net Income Q1 2012 · Mar 31, 2012 −$2.03M
Net Income Q1 2012 · Mar 31, 2011 −$95.79K
Cash And Equivalents Q1 2012 · Mar 31, 2011 $2.8K
Cash And Equivalents Q1 2012 · Dec 31, 2010 $3.13K